Teva推出优先票据为现有债务再融资

2026-09-07 16:57

Teva Pharmaceutical Industries (TEVA) to issue euro- and dollar-denominated senior notes through its finance subsidiaries, with proceeds primarily intended to refinance existing debt.
The company intends to redeem several outstanding notes, including up to $450M of 4.750% sustainability-linked notes due 2027 and up to €1.25B of 4.375% sustainability-linked notes due 2030.
Teva (TEVA) also plans to redeem all outstanding 6.750% senior notes due 2028, as well as all outstanding 7.875% and 7.375% sustainability-linked senior notes due 2029.
The planned redemptions are conditional on completion of the new notes offering, which itself is subject to market conditions. The new notes will be unsecured senior obligations issued through Teva’s finance subsidiaries and guaranteed by Teva, with any remaining proceeds available for general corporate purposes, including debt repayment.

More on Teva Pharmaceutical